Neuroimaging of Opioid Phase (OPAL)

The objective of the study is to determine differences in neurophysiology and behavior during different phases of opioid use in patients. Study activities will include neuroimaging (MRI and fMRI), behavioral tasks, sensory testing, blood draws, and questionnaires. The neuroimaging data will be analyzed using specialized software; data from questionnaires, sensory testing, and behavioral task performance will be analyzed using standard statistical software. Risks and safety concerns include standard, minimal risks associated with MRI scans, sensory testing, blood draws, and confidentiality.

Inclusion criteria

for Healthy Controls:

• female and ages 18+
• ability to read/understand English and give consent to participate
• no current or history of chronic pain
• not regularly taking any pain-relieving or mood-altering medications (per PI discretion)
• absence of use of opioid medications

Inclusion criteria

for Individuals with Chronic Pain:

• female and ages 18 +
• ability to read/understand English and give consent to participate
• self-reported or physician diagnosis of fibromyalgia and/or chronic pain
• current use of opioid medication(s) for inclusion in the opioid patient group -OR- absence of use of opioid medications for inclusion in the non-opioid patient group

Exclusion criteria

(for both groups):

• limited ability to participate fully in behavioral tasks, longitudinal follow-up
• MRI contraindication
• any factors that at the discretion of the investigators would adversely affect the participant or the integrity of the study
• male